本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Plus Therapeutics, Inc.

0.7879
-0.0548-6.50%
盤後0.7800-0.0079-1.00%19:56 EDT
成交量:92.45萬
成交額:73.37萬
市值:1,339.40萬
市盈率:-0.34
高:0.8250
開:0.8203
低:0.7721
收:0.8427
資料載入中...
2021/09/03

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/07/22

重要事件披露

8-K - Current report
2021/07/22

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/06

[修訂]季度報告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2021/05/20

重要事件披露

8-K - Current report
2021/04/22

重要事件披露

8-K - Current report
2021/04/22

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/03/05

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/26

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/02/26

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/26

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/26

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/23

重要事件披露

8-K - Current report
2021/02/22

重要事件披露

8-K - Current report
2021/02/22

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/12

重要事件披露

8-K - Current report
2020/11/03

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/29

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933